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Endolysins are peptidoglycan (PG) hydrolases that function as part of the bacteriophage (phage) 39 
lytic system to release progeny phage at the end of a replication cycle. Notably, endolysins alone 40 
can produce lysis without phage infection, which offers an attractive alternative to traditional 41 
antibiotics. Endolysins from phage that infect Gram-positive bacterial hosts contain at least one 42 
enzymatically active domain (EAD) responsible for hydrolysis of PG bonds and a cell wall binding 43 
domain (CBD) that binds a cell wall epitope, such as a surface carbohydrate, providing some 44 
degree of specificity for the endolysin. Whilst the EADs typically cluster into conserved 45 
mechanistic classes with well-defined active sites, relatively little is known about the nature of the 46 
CBDs and only a few binding epitopes for CBDs have been elucidated. The major cell wall 47 
components of many streptococci are the polysaccharides that contain the polyrhamnose (pRha) 48 
backbone modified with species-specific and serotype-specific glycosyl side chains. In this report, 49 
using molecular genetics, microscopy, flow cytometry and lytic activity assays, we demonstrate 50 
the interaction of PlyCB, the CBD subunit of the streptococcal PlyC endolysin, with the pRha 51 
backbone of the cell wall polysaccharides, Group A Carbohydrate (GAC) and serotype c-specific 52 
carbohydrate (SCC) expressed by the Group A Streptococcus and Streptococcus mutans, 53 
respectively.  54 





Endolysins are bacteriophage-encoded PG hydrolases that normally function from within the cell 57 
to lyse the bacterial host, releasing progeny phage and completing the phage lifecycle [1]. 58 
However, the lytic activity of endolysins can be harnessed for antimicrobial use due to their ability 59 
to equally lyse bacteria when applied exogenously, without infection by a parental phage. Due to 60 
their direct lytic action on target PG, endolysins are not affected by efflux pumps, alterations in 61 
metabolism, or other mechanisms of antibiotic resistance, making them ideal candidates for 62 
development against multi-drug resistant organisms [2-4]. Notably, at least three endolysins, 63 
some of which are active against methicillin-resistant Staphylococcus aureus, are currently being 64 
evaluated in human clinical trials for their antimicrobial activity (reviewed in [5]).    65 
 66 
Most endolysins, and in particular those from phage that infect Gram-positive bacterial hosts, are 67 
comprised of modular domains. An enzymatically active domain (EAD) is generally found in the 68 
N-terminal region, while a cell wall-binding domain (CBD) is located in the C-terminal region [6]. 69 
As the name implies, the EAD is a catalytic domain that is responsible for cleaving specific bonds 70 
in the PG, the nature of which is dependent on the mechanistic class of the EAD. Occasionally, 71 
endolysins contain two EADs, although both are not necessarily active. The CBD binds at high 72 
affinity [7] to a cell wall-specific epitope and was suggested to dictate genus, species and serovar-73 
specificity of the endolysin. The CBD targets may be surface carbohydrates, wall teichoic acids 74 
linked to the Gram-positive bacterial cell wall, or the PG itself [8].  75 
 76 
The endolysin now known as PlyC is one of the first described endolysins and remains one of the 77 
most studied. In 1934, Alice Evans noted a “nascent lysis” activity derived from streptococcal 78 
phage lysates on streptococcal strains that were not sensitive to the phage itself [9]. By 1957, 79 
Krause had determined that the phage used by Evans was specific for Group C Streptococci 80 




Streptococci (GAS, GAVS, and GCS, respectively) [10]. These findings were confirmed by 82 
Maxted later the same year and extended to include Group E Streptococci (GES) [11]. In 2001, 83 
PlyC, then referred to as the streptococcal C1 lysin, became the first endolysin to be used 84 
therapeutically, protecting mice from GAS challenge in a nasopharyngeal model [2]. Subsequent 85 
studies revealed that PlyC is a structurally unconventional endolysin, which is not encoded by a 86 
single gene as found for all other endolysins described to date. Rather, PlyC is a nine-subunit 87 
holoenzyme encoded by two distinct genes, plyCB and plyCA, within a polycistronic operon [12]. 88 
Eight PlyCB subunits self-assemble into a ring structure and form the basis of the CBD that binds 89 
the streptococcal surface. A single PlyCA subunit contains two distinct EADs separated by an 90 
extended α-helical linker region, which interfaces with the N-terminal residues of the PlyCB 91 
octamer [13]. The PlyCA EADs consist of a glycosyl hydrolase (GH) domain and a cysteine, 92 
histidine-dependent aminohydrolase/peptidase (CHAP) domain. The very high lytic activity of 93 
PlyC relative to other endolysins is attributed to synergy/cooperativity between the two EADs.  94 
 95 
Although the EADs of PlyCA have been extensively characterized with respect to specificity of 96 
PG bonds they cleave, active-site residues, and their synergistic activity, it is unclear how PlyCB 97 
recognizes PG of GAS, GCS and GES. Similar to other Gram-positive bacteria, the plasma 98 
membrane of streptococci is surrounded by thick cell wall that consists of a complex network of 99 
PG with covalently attached polysaccharides. Rebecca Lancefield utilized the unique 100 
immunogenicity of the surface carbohydrates in -hemolytic streptococci to subsequently 101 
separate them into serogroups [14]. S. pyogenes is categorized as Group A Streptococcus, whilst 102 
S. dysgalactiae subsp equisimilis (SDSE) produce at least two types of carbohydrates and are 103 
annotated as Group C and G Streptococci, respectively [15]. Pioneering work by many 104 
researchers have revealed that the cell wall polysaccharides of GAS, GCS and S. mutans, consist 105 
of a pRha backbone modified with species-specific and serotype-specific glycosyl side chains 106 




Lancefield group A carbohydrate (GAC), group C carbohydrate (GCC), and SCC, respectively, 108 
have a conserved repeating →3)α-Rha(1→2)α-Rha(1→ di-saccharide backbone [16, 17]. The β-109 
N-acetylglucosamine (GlcNAc) side chains are attached to the 3-position of the α-1,2 linked 110 
rhamnose (Rha) in GAC [16, 18, 19]. The GCC side chains have two N-acetyl-galactosamine 111 
(GalNAc) residues attached to the same hydroxyl of Rha [16, 18, 20]. SCC carries the α-glucose 112 
(Glc) side chains attached to the 2-position of the α-1,3 linked Rha in SCC [17]. Additionally, the 113 
side chains of GAC and SCC are decorated in parts with the glycerol phosphate (GroP) moiety 114 
[21]. The GAC and SCC biosynthetic pathways are encoded by the 12-gene loci 115 
gacABCDEFGHIJKL and sccABCDEFGHMNPQ, respectively. The molecular mechanisms of 116 
GAC and SCC biosynthesis have been the focus in a number of recent studies [21-25]. 117 
 118 
Remarkably, extracted GAC is known to partially inhibit the lytic actions of PlyC [26]. Furthermore, 119 
a GAS mutant carrying the unmodified GAC (lacking the GlcNAc side chains) displayed enhanced 120 
susceptibility to PlyC [25], implicating PlyCB in recognition of the pRha backbone. Here, we 121 
identify the pRha backbone of GAC as the definite minimal binding epitope for PlyCB.  122 
 123 
Materials and Methods  124 
Bacterial strains, growth conditions and media 125 
Streptococcus pyogenes strain D471 was propagated on solid media in plates containing Todd-126 
Hewitt broth supplemented with yeast extract (0.2%) (THY) and agar (1.4%) or in liquid THY as 127 
described by Gera et al [27]. S. mutans wild type (Xc) and mutants were grown in Todd-Hewitt 128 
broth with 1% yeast extract. All cultures were grown without antibiotics and without aeration at 129 
37°C. E. coli genotypes DH5 (NEB, cat. No. C2988J), DH10 (Thermo Fisher, cat No. 130 
18297010), BL21 (NEB, cat No. C2530H) and Origami 2 (Millipore Sigma, cat. No. 71346) were 131 




medium supplemented with either 50 µg/ml kanamycin, 100 µg/ml ampicillin or 35 µg/ml 133 
chloramphenicol as needed. 134 
 135 
Bacterial strains E. coli CS2775 were transformed with pRGP1 plasmid [28], gacABCDEFG [23] 136 
to produce pRha or empty plasmid control (pHD0131). The bacterial cells were grown overnight 137 
in LB containing erythromycin (150 μg/ml) at 37°C and used next day for whole cell Western blots 138 
and FACS and microscopy analysis.  139 
 140 
Recombinant expression and purification of PlyCBWT and PlyCBR66E 141 
PlyCBWT (GenBank ID: NC_004814.1:7517-7735) was expressed from a pBAD24 vector and 142 
purified from BL21 cells as previously described [12]. In brief, the culture was grown in LB and 143 
induced with 0.25% L-arabinose at OD600 ~1.2-1.4 (Alfa Aesar, cat no. A11921). Cultures were 144 
grown at 37°C with shaking at 180 RPM for 3-4 hours, centrifuged at 4500 x g and resuspended 145 
in phosphate-buffered saline (PBS). Lysis was performed by a French press (1800 psi). 146 
Benzonase (Millipore Sigma, cat. No. 70746-3) was added and the lysate incubated at room 147 
temperature with rotation for 20-30 min. The lysate was centrifuged at 20,000 x g for 20 min and 148 
the cleared lysate was passed through a 0.45-µm filter and loaded onto a XK-26/20 column 149 
(Cytiva) with 30-35 ml ceramic hydroxyapatite (Bio-Rad, cat no. 1582000). PlyCBWT was eluted 150 
from the column with three column volumes of 1 M sodium phosphate buffer (pH 7.2). Protein 151 
was subsequently dialyzed in PBS, 10% glycerol and stored at -80°C until use. Protein purification 152 
of PlyCBR66E was performed as PlyCBWT [13]. The fluorescent labeling of PlyCBWT and PlyCBR66E 153 
was performed using the manufacturer’s recommended guidelines (Thermo Fisher, cat. No. 154 
A20174). Analytical gel filtration was used to determine the multimeric nature of PlyCB and 155 
PlyCBR66E. A total of 100 µl (0.1 mg) of each protein was applied to a Superose 12 10/300 GL 156 
column (Cytiva) and run in isocratic conditions in PBS buffer for 1.5 column volumes on an AKTA 157 





Purification of GAC 160 
GAS cells were grown overnight in THY media at 37˚C. Cultures were centrifuged at 4,500 x g. 161 
Pellets were washed and resuspended in 40 ml distilled water per each original liter of media 162 
used and combined in an 800 ml beaker. 22.5 ml 4N sodium nitrite (5 ml per liter of culture) was 163 
added to the beaker in addition to 22.5 ml glacial acetic acid (5 ml per liter of culture). An orbital 164 
shaker was used to gently mix the beaker for 15 min in a hood. The mixture was centrifuged in 165 
500 ml bottles at 8000 x g for 15 min. The supernatant was decanted to a new beaker and 166 
neutralized with 1M sodium hydroxide. The total solution, about 300 ml, was filtered with a 0.45-167 
micron filter assembly. 50-50 ml aliquots were deposited in a 3.5 kDa membrane and dialyzed in 168 
a 4-liter beaker overnight with water. The following day, the solution was concentrated using an 169 
Amicon 400 ml stirred cell (model 8400) filter assembly with a 76 mm diameter Ultracel® 5 kDa 170 
ultrafiltration disc (Millipore Sigma, cat. No. PLCC07610) for 2 hours with 60 psi. The ~10 ml 171 
concentrate was loaded onto an S-100 column for final purification. Fractions were assayed for 172 
Rha, lyophilized and stored at 4°C until use. 173 
 174 
Calculation of pRha concentration 175 
A modified protocol by Edgar et al. [21] based on a protocol from DuBois et al. [29] was used to 176 
determine Rha concentration in purified GAC. Briefly, anthrone reagent was prepared by 177 
dissolving 0.2% w/w anthrone in H2SO4. Eighty microliters of aqueous samples or standards 178 
containing either GAC or L-Rha at known concentrations were added to a 1.5 ml microfuge tube. 179 
To this same tube, 320 µL of the anthrone reagent was added. Samples were boiled at 98°C for 180 
10 min in a heat block. Samples were cooled to room temperature, transferred to a quartz plate, 181 
and the absorbance at 580 nm was recorded using a spectrophotometer. Rha concentration was 182 





Precipitation of PlyCB with GAC 185 
PlyCBWT and PlyCBR66E samples were defrosted from storage at -80°C. Lyophilized GAC was 186 
resuspended in PBS. Both proteins and GAC were added to a 3.5 kDa dialysis membrane and 187 
dialyzed overnight in PBS. Protein concentrations were determined using a NanoDrop 188 
spectrophotometer (Thermo Fisher ND-2000) at 280 nm and were diluted to 5 mg/ml. The GAC 189 
was also assayed and diluted with PBS to 1.6 mg/ml. One-hundred microliters of proteins and 190 
100 µl of GAC or PBS were mixed in a 250 µl quartz plate and allowed to incubate without shaking 191 
at room temperature. Visible precipitate formed in samples in 5-8 minutes. After recording the 192 
precipitate at 340 nm using a Spectramax® M5 (Molecular Devices) spectrophotometer, the total 193 
sample volume was transferred to a 1.5 ml microfuge tube. Samples were centrifuged at 14,000 194 
x g to pellet the precipitate and supernatants were transferred to new 1.5 ml microfuge tubes. 195 
Two-hundred microliters of 8 M urea was added to the pellet. Pellets were resuspended and 5 µl 196 
of either pellet or supernatant were added to 40 µl water with 8 µl 6x Laemmli buffer with DTT. 197 
Samples were boiled at 98°C for 8 min, and then 12.5 µl were loaded onto a 7.5% SDS-PAGE 198 
and run for 32 min at 200 V. Proteins were visualized using Coomassie stain.  199 
 200 
Lysis assay 201 
A turbidity reduction assay was used to ascertain strain sensitivity to PlyC. This assay was 202 
performed as previously described [30], except PlyC was used at 2 µM. Eight technical replicates 203 
were performed.  204 
 205 
Sensitivity of streptococcal species to PlyC-mediated lysis was analyzed using a wide range of 206 
clinical isolates: 1) GAS isolates: M1UK, WT 5448 strain [M1], deltagacI 5448 strain [dgacI]; 2) 207 
GCS isolate: stC74A.0; 3) SDSE_gac isolates: stG245.0, stG652.0. stG485.0; GGS: stG6.0, 208 
stG485.0 and 4) S. mutans serotype c were used as negative controls. Briefly, all streptococcal 209 




in THB media. Next day, the bacterial cells were inoculated in 1:100 fresh media and grown until 211 
mid-logarithmic phase (OD600 1.0). The cells were washed in PBS and resuspended to an OD600 212 
of 2.0. In a 96-well plate, to a 100 µl of bacterial cells, 100 µl of PlyC [1 µg/ml] was added and 213 
immediately read at an absorbance of OD600. The obtained values were standardized by 214 
subtracting from the background values. The data is plotted using GraphPad Prism version 9.  215 
 216 
SDS-PAGE and blotting analysis 217 
PlyCBWT binding to recombinant E. coli expressing pRha was conducted using blot analysis. 218 
Briefly, the lysate from the overnight cultures was analyzed in 20% tricine gels. SDS-PAGE and 219 
protein transfers were performed according to manufactures instructions, Atto Ae-6050 Mini Gel 220 
chamber and Novex protein separation from Thermo Fisher, respectively. The PVDF membranes 221 
were blocked with 5% non-fat dry milk with Tris-Buffered Saline, 0.1% Tween® 20 detergent prior 222 
to incubation with PlyCBWT labelled with Alexa Fluor® 647 (1:1000) for one hour at room 223 
temperature. Goat anti-rabbit GAC antibodies conjugated with IRDye® 800CW were used as a 224 
positive control (abcam ab216773). The resulting blots were imaged using the Licor Odyssey FC 225 
Imaging System. All the blots were processed in parallel under the same conditions.  226 
 227 
Microscopy 228 
Microscopic analysis of E. coli bacteria was performed using cells that were grown overnight in 229 
LB supplemented with antibiotics at 37˚C and diluted 1:100 the next day and regrown until OD600 230 
reached 0.5. The cells were washed twice with PBS for 5 min at 10,000 rpm and stained with 231 
1:1000 dilution of PlyCBAF647 and left for 20 minutes on ice in the darkness. Prior to fixing the cells 232 
with 4% paraformaldehyde, the cells were washed again with PBS. The fixed cells were mounted 233 
on 1% agarose coated microscopic slides and viewed under the CY5 channel on a fluorescent 234 





FACS analysis 237 
E. coli cells were grown overnight as described above and diluted 1:100 the next day, grown at 238 
37˚C and used for the assay at OD600 = 0.5. The cells were washed with PBS and probed with 239 
PlyCBAF647 or PlyCBR66EAF647 at 1:1000 dilution at 1:1000 dilution. Anti-GAC antibodies conjugated 240 
with FITC (ABIN238144, antibodies-online, titer 1:50) were used as a positive control. The 241 
samples were incubated for 20 minutes on ice at dark conditions. The cells were washed twice 242 
with PBS at 14,000 rpm for 5 minutes and fixed with 4% paraformaldehyde. BD LSRFortessa 243 
Flow Cytometry software was used to analyse the samples and the data interpretation was 244 
conducted with FlowJoTM software v10.6.2. 245 
 246 
PlyC hydrolysis of sacculi 247 
S. mutans wild-type (WT) and the mutant strain sacculi were obtained by the SDS-boiling 248 
procedure [25] followed by four washes each with 1 M NaCl and distilled water. The sacculi were 249 
resuspended in PBS to OD600 of 1.0 and incubated with PlyC (5 µg/ml) in a 96-well plate. The 250 
lysis was monitored after 10, 20, 30, 40, 50 and 60 min as a decrease in OD600. Results were 251 
reported as fold change in OD600 of the sacculi incubated with PlyC vs the sacculi incubated 252 
without PlyC.  253 
 254 
 255 
Results & Discussion 256 
 257 
Pathogenic streptococci producing the GAC are susceptible to PlyC  258 
A major component of the GAS cell wall is the GAC, building approximately 50% of the cell wall 259 
by weight [31]. The GAC is universally conserved amongst all isolated GAS strains on the basis 260 
of the gene cluster sequence conservation [32]. A number of S. dysgalactiae subsp. equisimilis 261 




undergone homologous recombination and replaced their Group G Carbohydrate (GGC) gene 263 
cluster in parts with the GAC gene cluster [33-35]. We therefore expanded the previously reported 264 
PlyC streptococci cell lysis assay used by Nelson et al. [2] to investigate those new isolates named 265 
SDSE_gac. We also tested if PlyC was able to lyse a selection of GAS serotypes including a 266 
newly emerged isolate M1UK [36], and included negative controls GGS isolates and S. mutans 267 
serotype C (Fig. 1B). In agreement with the published literature, all tested GAS serotypes are 268 
susceptible to PlyC lysis and the two GGS isolates are resistant to PlyC. The GGC does not 269 
contain the GAC, GCC and SCC pRha backbone with →3)α-Rha(1→2)α-Rha(1→ di-saccharide 270 
repeats, but an alternating Rha-Gal carbohydrate [37] (Fig. 1A). All three SDSE_gac isolates 271 
tested have inherited parts of the gac gene cluster and produce the GAC instead of the GGC [34]. 272 
Strikingly, the SDSE_gac strains are all sensitive to PlyC treatment. The fact that PlyC is able to 273 
lyse SDSE_gac strains that express the GAC, but PlyC does not lyse the isogenic GGS strains 274 
producing the GGC strongly suggests that the GAC is a critical component of PlyC recognition 275 
and subsequent activity.  276 
 277 
Importantly, all strains tested in this study that are susceptible to PlyC lysis produce a cell wall 278 
polysaccharide that contains the pRha backbone and a -linked sugar substituent on the 1,2-279 
linked Rha (Fig 1A). We therefore suggest that the pRha backbone with and without a side chain 280 
are both vital ligands to assist PlyC activity and the new SDSE_gac isolates will also be 281 
susceptible to PlyC treatment due to production of the GAC. 282 
 283 
Purified GAC precipitates PlyCB - but not PlyCBR66E  284 
The lysis assay of GAS cells, and in particular of the SDSE_gac variants, suggests that either the 285 
ubiquitous pRha or GAC in GAS cells is the ligand for PlyCB. We propose that the PlyCB 286 
octameric CBD binds GAC and/or the GAC pRha backbone. We tested this hypothesis by 287 




to precipitate PlyCB, an interaction of the two systems must have occurred [38]. As a negative 289 
control, we employed the previously published inactive mutant PlyCBR66E, which lost the ability to 290 
bind to GAS cells [13]. Consistent with prior analytical gel filtration and dynamic light scattering 291 
results [12], as well as the crystal structures [13, 39, 40], both PlyCB and its R66E mutant self-292 
assemble into stable octameric structures (Fig 1C, SF 1). The purified proteins were incubated 293 
with the extracted GAC, and precipitation was monitored at 340 nm, a standard wavelength for 294 
measuring protein aggregation [41, 42] (Fig. 2A, B). Whilst keeping the PlyCB concentration 295 
constant, we varied the concentration of GAC. Within five minutes at room temperature the 296 
solution became turbid, suggesting aggregation (Fig. 2A). When the PlyCB concentration was 297 
kept constant and the GAC concentration was varied, the turbidity correlated with PlyCB 298 
concentration in a dose dependent manner, suggesting that PlyCB requires GAC to aggregate. 299 
Importantly, PlyCB did not self-aggregate when no GAC was added in the assay. Furthermore, 300 
no aggregation was detected when PlyCBR66E was incubated with purified GAC (Fig. 2B). To 301 
demonstrate the presence of PlyCB in the precipitates, we analyzed the soluble and pellet 302 
fractions (Fig. 2C, D). A higher yield of aggregated PlyCB was found in the pelleted samples when 303 
compared to the soluble fraction (Fig. 2D). A similar precipitation effect was observed when we 304 
varied the PlyCB concentration and kept the GAC concentration constant (Fig. 2E, F), 305 
demonstrating that both species are necessary for an interaction.  306 
 307 
 308 
PlyCB binds to recombinantly produced pRha backbone  309 
The purified GAC from bacteria contains a mixture of carbohydrates, including the fully decorated 310 
GAC with GroP[21] and a small proportion of the polysaccharide lacking the side chains [43]. PlyC 311 
is able to lyse a number of GAS mutants including GAVS and dgacI_M1 [2, 11, 25, 44], that 312 
decorate the cell wall with the unmodified GAC lacking the side chains (Fig. 1A, B), suggesting 313 




binding. To test this hypothesis, we recombinantly produced the pRha backbone in E. coli cells. 315 
We and others have previously reported that the S. mutans sccABCDEFG gene cluster, when 316 
transformed into E. coli cells, functionally produces the pRha backbone attached to the lipid A 317 
[23, 28]. Additionally, to understand if PlyCB recognizes a specific pRha backbone, we 318 
engineered E. coli cells expressing the GAC gene cluster gacABCDEFG required for the GAC 319 
pRha production. E. coli cells carrying an empty plasmid were used as a negative control.  320 
 321 
Next, we investigated the binding of PlyCB conjugated with Alexa Fluor® 647 (PlyCBAF647) to an 322 
E. coli total cell lysate expressing the pRha backbone of the SCC or GAC, respectively (Fig. 3A). 323 
The blotted membranes were incubated with PlyCBAF647, and a positive interaction between 324 
PlyCBAF647 and the E. coli produced pRha is visualized as a prominent band around 40 kDa. The 325 
size of the band agrees with the band detected by anti-GAC antibodies that were previously 326 
reported to recognize pRha [23] (Fig. 3B). Importantly, PlyCBAF647 and GAC antibodies do not 327 
interact with the cell lysate of E. coli expressing an empty plasmid (Fig. 3 A, B). Contrary, the 328 
R66E-mutant protein was not able to detect the pRha of the PAGE separated sample (SF 2). We 329 
further confirmed the ability of PlyCB to bind to E. coli cells decorated with the pRha by fluorescent 330 
microscopy (SF 3). Only cells that produce the pRha are detected by the PlyCBAF647, in agreement 331 
with the results of the blot analysis. 332 
 333 
To gather additional evidence that PlyCB interacts with the pRha backbone, we established a flow 334 
cytometry assay to analyse the binding of PlyCBAF647 to pRha-producing E. coli. Unstained E. coli 335 
cells that express pRha or carry an empty plasmid sort in the identical range (Fig. 4A). The GAC 336 
antibodies label exclusively the cells producing pRha (Fig. 4A). A similar pattern of the GAC 337 
antibodies binding is observed when the cells were incubated with PlyCBAF647 (Fig. 4B). Contrary, 338 
the PlyCBR66EAF647 mutant protein does not bind to E. coli cells, and PlyCBAF647 does not interact 339 




definitive evidence that the pRha backbone of GAC and SCC is a binding receptor of the PlyCB 341 
octameric subunit. 342 
 343 
PlyC lyses engineered S. mutans producing the GAC 344 
Despite the fact that the SCC pRha backbone is identical to the GAC, S. mutans is resistant to 345 
PlyC lysis (Fig. 1A). To get a better understanding why S. mutans is resistant to PlyC, we 346 
compared PlyC-induced lysis of the sacculi purified from S. mutans WT and a number of mutant 347 
strains producing different SCC variants (Fig. 5). First, we examined the ΔsccH mutant producing 348 
the GroP-deficient SCC [21]. Similar to S. mutans WT, ΔsccH was resistant to PlyC-mediated 349 
lysis (Fig. 5). Second, we tested the sccN deletion mutant, ΔsccN, that is deficient in the enzyme 350 
required for generation of the Glc side chains [45]. A time dependent lysis is observed for ΔsccN. 351 
Expression of the WT copy of sccN in ΔsccN (the ΔsccN:psccN strain) fully restored the resistance 352 
of the bacteria to PlyC (Fig. 5). These observations clearly suggest that PlyC is able to bind to the 353 
S. mutans cells producing the unmodified pRha backbone, and the Glc side chains in SCC hinders 354 
PlyC binding. We then investigated whether the addition of the GAC GlcNAc side chains to the 355 
pRha backbone affects sensitivity of the engineered S. mutans sacculi to PlyC-induced lysis. We 356 
expressed the GAS genes gacHIJKL required for the formation and addition of the GlcNAc side 357 
chains and GroP to GAC [21], in the ΔsccN background strain in two versions, creating the 358 
ΔsccN:pgacHI*JKL and ΔsccN:pgacHIJKL strains [45]. The plasmid pgacHI*JKL contains an 359 
inserted stop codon in the gacI gene required for generation of the GlcNAc side chain, and, 360 
therefore, the ΔsccN:pgacHI*JKL strain produces the unmodified SCC lacking any side chains 361 
(Fig. 5). As expected, the sacculi isolated from this strain remains susceptible to PlyC lysis. We 362 
previously showed that in ΔsccN:pgacHIJKL, the Glc side chains are replaced with the GlcNAc 363 
side chains [45]. Interestingly, expression of gacHIJKL in ΔsccN did not restore the resistance of 364 
the bacteria to PlyC (Fig. 5), indicating that the GlcNAc side chains do not obstruct PlyC binding. 365 




deficient in SCC expression [45]. The RgpG protein catalyzes the first step in SCC biosynthesis 367 
[46]. In comparison to ΔsccN, PlyC-induced lysis of ΔrgpG was less pronounced (Fig. 5), 368 
indicating the importance of the pRha backbone of SCC in PlyC activity and supporting the 369 
findings that the pRha backbone is a ligand contributing to PlyC binding. These studies reveal 370 
that if the SCC is ‘unmasked’ i.e., stripped of the Glc and Glc-GroP side chains, it becomes a 371 
ligand for PlyCB and that S. mutans is PlyC susceptible if SCC is replaced with GAC.  372 
 373 
 374 
Concluding remarks 375 
 376 
A structural feature of the PlyCB protein remains to be discovered that explains why only certain 377 
streptococci are susceptible to PlyC’s lytic activity. The pRha decorated with an −linked side 378 
chain sugar appears not compatible with the PlyCB ligand binding site and therefore only those 379 
streptococci expressing pRha decorated with -linked substituents, such as GlcNAc and GlcNAc-380 
GroP are susceptible. This could potentially be exploited for diagnostic purposes or in the case of 381 
SCC and Group G Streptococci, opens up the potential for novel therapeutic approaches. If SCC 382 
was treated by PlyC in combination with an additional enzyme that removes the −linked side 383 
chains in these streptococcal carbohydrates, this would expose the pRha backbone and 384 
subsequently make these strains susceptible. A recently accepted manuscript by Boendum et al. 385 
[40] reported 19 potential binding states of tetrarhamnose to PlyCB. Once the pRha ligand site 386 
has been identified, this could also be further exploited by directed evolution approaches to 387 
generate PlyCB protein variants that are capable to bind the carbohydrates from, for example, 388 
SCC and Group G Streptococci.  389 
 390 
Whilst much has been learned about the structure and function of PlyC in the past 20 years, many 391 




length of the cellular pRha is 7-10 kDa [25] and that the 1,2-1,3-pRha with or without -393 
configured GlcNAc/GalNAc-side chains bind to PlyCB, it is inviting to speculate that an element 394 
of avidity is responsible for tight binding of the PlyCB octamer to the streptococcal surface, in 395 
agreement with the recent accepted manuscript [40]. Further proof is needed to substantiate this 396 
hypothesis. Another question lies in the actions of the EADs relative to the PlyCB octamer. PlyC 397 
clearly has a high turnover as demonstrated in multiple biochemical assays. However, it is 398 
unknown if PlyCB “docks” to the surface and the flexibility of the holoenzyme allows the PlyC 399 
EADs to cleave multiple bonds in a localized area weakening the overall superstructure of the 400 
PG. Alternatively, the enzymatic turnover could be dictated by a balance of on and off rates of the 401 
EADs and CBD monomers leading to widespread hydrolysis of the PG. Lastly, it is unknown 402 
whether PlyC binds, cleaves, and releases the PG at random points on the streptococcal surface 403 
or works its way down a single strand of PG in a processive manner. It is noteworthy that cellulase 404 
enzymes, which cleave the 1,4 glycosidic linkages in cellulose, possess a catalytic domain, a 405 
flexible linker, and a cellulose binding domain, analogous to the traditional endolysins. It has been 406 
demonstrated that energy is stored in the flexible linker can adopt compact and extended 407 
configurations that allows the cellulase to move in a “caterpillar-like” motion down a chain of 408 
cellulose [47, 48]. Although PlyC does not contain an equivalent flexible linker, the octameric 409 
nature of PlyCB invites the possibility that it may interact with the successive pRha strands 410 
allowing PlyC to depolymerize the PG in a zipper-like fashion.   411 
 412 
In conclusion, the 1,2-1,3-pRha is the definite, minimal carbohydrate substrate for the PlyCB 413 
subunit. We validated this by comprehensive experiments, using pRha recombinantly produced 414 
in E. coli, and the S. mutans variants of the Rha-based polysaccharides. The work described here 415 
provides valuable insight into the molecular interactions that define a PlyC’s host specificity, which 416 
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Figure Legend  429 
Fig 1) 430 
A) Symbolic drawings of the carbohydrate structures of GAS (GAC), polyrhamnose backbone 431 
(pRha) in GAVS and M1_dgacI, GCS (GCC), GGS (GGC) and S. mutans (SCC). For simplicity, 432 
the reported glycerol phosphate of occasionally present on the GAC and SCC side chains have 433 
been omitted. Repeat units are marked with brackets. The pRha backbone with alternating (α1-434 
>2) and (α1->3) linkages, whilst the α1->2 Rha being decorated with a β1->3 side chain is a 435 
commonality among all PlyC susceptible strains. B) PlyC lysis of streptococcal pathogens. Group 436 
A and Group C Streptococci serotypes are susceptible to PlyC-mediated lysis. Group G 437 
Streptococci show limited susceptibility and S. mutans is resistant to PlyC lysis. Three SDSE 438 
isolates that produce the GAC instead of GGC (SDSE_gac) are susceptible to PlyC treatment. C) 439 
Bottom and top view onto WT PlyCB octameric structure with the GlyH and EAD domains omitted 440 
(4f78.pdb). 441 
 442 




Precipitation studies of purified PlyCB and GAC reveal direct interaction of PlyCB with GAC. A) 444 
The PlyCB concentration is kept constant whilst the GAC concentration is varied. Visible 445 
precipitate forms at the higher concentrations. B) The precipitate level is measured 446 
spectrophotometrically at 340 nm and compared to the mutant PlyCBR66E, which does not bind 447 
the GAC. C) Coomassie stained and D) densitometry analysis of PlyCB protein from the 448 
supernatant fraction and aggregates (pellets). E, F) The same dose dependency is observed 449 
when the PlyCB concentration is varied. Arrowhead depicts PlyCB protein at 8 kDa. 450 
 451 
Fig 3) 452 
Representation of immunoblot analysis of the cell lysate of E. coli expressing the SCC and GAC 453 
pRha and carrying an empty control plasmid (-ve). A) Blot was incubated with PlyCB-Alexa Fluor® 454 
647 (PlyCBWTAF647). B) Probing the same samples with the GAC antibodies confirms the presence 455 
of GAC in the bands. Molecular mass markers are given in kDa. 456 
 457 
Fig 4) 458 
PlyCB binding to E. coli cells were investigated by flow cytometry after labelling with PlyCBWTAF647 459 
and PlyCBR66EAF647 mutant proteins. Blue: -ve control cells without pRha. Red: pRha producing E. 460 
coli cells. Representative histograms are shown. A) Left panel: unstained cells. Right panel: The 461 
anti-GAC antibodies (GAC-FITC) were used as a positive control to label the E. coli cells 462 
producing pRha. The antibodies do not bind to the E. coli cells carrying an empty plasmid (-ve). 463 
B) Left panel: PlyCBWTAF647 binds to the E. coli cells producing pRha, but not to the E. coli cells 464 
carrying an empty plasmid (-ve). Right panel: PlyCBR66EAF647 does not binds to the E. coli cells 465 
producing pRha. 466 
 467 




The PlyC-mediated lysis of sacculi purified from S. mutans strains. The lysis was monitored after 469 
10, 20, 30, 40, 50 and 60 min as a decrease in OD600. Results are presented as a fold change in 470 
OD600 of the sacculi incubated with PlyC vs. the sacculi incubated without PlyC. Data points and 471 
error bars represent mean values of four biological replicates and standard deviation, 472 
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Fig 1) 
A) Symbolic drawings of the carbohydrate structures of GAS (GAC), polyrhamnose backbone (pRha) in GAVS and 
M1_dgacI, GCS (GCC), GGS (GGC) and S. mutans (SCC). For simplicity, the reported glycerol phosphate of occa-
sionally present on the GAC and SCC side chains have been omitted. Repeat units are marked with brackets. The 
pRha backbone with alternating (!1->2) and (!1->3) linkages, whilst the !1->2 rhamnose being decorated with 
a "1->3 side chain is a commonality among all PlyC susceptible strains. B) PlyC lysis of streptococcal pathogens. 
Group A and Group C Streptococci serotypes are susceptible to PlyC-mediated lysis. Group G Streptococci show 
limited susceptibility and S. mutans is resistant to PlyC lysis. Three SDSE isolates that produce the GAC instead of 
GGC (SDSE_gac) are susceptible to PlyC treatment. C) Bottom and top view of the WT PlyCB octameric ring struc-
ture with the GlyH and EAD domains omitted (4f78.pdb).
A)
pRha backbone 
(M1_dgacI and GAVS) 
Serotype C Carbohydrate (SCC)
_-Glc (1,2)
Group G Carbohydrate (GGC)
_-GalNAc (1,4)









































































Precipitation studies of puri!ed PlyCB and GAC reveal direct interaction of PlyCB with GAC. A) The PlyCB 
concentration is kept constant whilst the GAC concentration is varied. Visible precipitate forms at the higher 
concentrations. B) The precipitate level is measured spectrophotometrically at 340 nm and compared to the 
mutant PlyCB_R66E, which does not bind the GAC. C) Coomassie stained and D) densitometry analysis of PlyCB 
protein from the supernatant fraction and aggregates (pellets). E, F) The same dose dependency is observed 
when the PlyCB concentration is varied. Arrowhead depicts PlyCB protein (8 kDa).
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Fig 3) 
Representation of immunoblot analysis of the cell lysate of E. coli expressing the SCC and GAC pRha and carrying 
an empty control plasmid (-ve). A) Blot was incubated with PlyCB-Alexa Fluor® 647 (PlyCB-WT-AF647). B) Probing 
the same samples with the GAC antibodies con!rms the presence of GAC in the bands. Molecular mass markers 
are given in kDa.
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Fig 4) 












































The PlyC-mediated lysis of sacculi puri!ed from S. mutans strains. The lysis was monitored after 10, 20, 30, 40, 50 
and 60 min as a decrease in OD600. Results are presented as a fold change in OD600 of the sacculi incubated with 
PlyC vs. the sacculi incubated without PlyC. Data points and error bars represent mean values of four biological 






























SF 1) Gel filtration purification of WT and R66E-PlyCB proteins. PlyCBWT (blue) and PlyCBR66E (red) 
proteins elute at a rentention volume of 12 mL. The PlyCB octamer has a theoretical mass of 63.8 kDa, with 
a monomeric mass of 7.9 kDa. Gel filtration standards are shown in kDa and include bovine thyroglobulin 
(670 kDa, void volume), bovine gamma-globulin (158 kDa), chicken ovalbumin (44 kDa), horse myoglobin 











PlyCB binds to pRha in E. coli cell lysate whilst PlyCBR66E does not. A) Representative membrane blots 
showing that only PlyCB wildtype protein binds to total E. coli lysate when the pRha is expressed from the 
SCC gene cluster. PlyCBR66E fails to bind to pRha. B) Control dot blots showing that both PlyCB proteins are 
fluorescently labelled and detected when spotted directly onto nitrocellulose membrane (1:1000 dilution - 
identical to Figure A).
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PlyCB binds to pRha expressing E. coli cells analysed using microscopic analysis: Representation of 
microscopic graph shows defined elongated PlyCBWT stained E. coli bacterial cells suggesting that PlyCB 
binds specifically to SCC_pRha cells but not to E. coli cells lacking pRha expression (-ve) detected using 
CY5 channel. 
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